Hepatic plasma flow estimated according to fick's principle in patients with hepatic encephalopathy: Evaluation of indocyanine green and D-sorbitol as test substances

Hepatology

Volumn 27, Issue 3, 1998, Pages 666-673

  Clemmesen, Jens Otto ^a,b   Tygstrup, Niels ^a   Ott, Peter ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalei ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN; SORBITOL;

ADULT; ARTICLE; CHEMICAL REACTION KINETICS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; FEMALE; FIRST PASS EFFECT; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER FAILURE; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; VEIN CATHETERIZATION;

ADULT; COLORING AGENTS; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRCULATION; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; ORGANIC CHEMICALS; SORBITOL;

EID: 0031891517     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270305     Document Type: Article

References (20)

1. Köppel C, Pohle S, Müller C. Rapid determination of functional liver plasma flow in ICU patients by a modified hepatic D-sorbitol plasma clearance method. Eur J Drug Metab Pharmacokinet 1993;18:327-331.
2. Haderigue A, Lebrec D, Moreau R, Sogni P, Durand F, Gaudin C, Bernuau J, et al. Persistence of systemic and splancnic hyperkinetic circulation in liver transplant patients. HEPATOLOGY 1993;17:175-178.
3. Bircher J, Blankart R, Halpem A, Häcki W, Laisue J, Preisig R. Criteria for assessment of functional impairment in patients with cirrhosis of the liver. Eur J Clin Invest 1973;3:72-85.
4. Navasa M, Feu F, García-Pagán JC, Jiménez W, Llach J, Rimola A, Bosch J, et al. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. HEPATOLOGY 1993;17:355-360.
5. Bradley SE, Ingelfinger FJ, Bradley GP, Curry JJ. The estimation of hepatic blood flow in man. J Clin Invest 1945;24:890-897.
6. Wiegand BD, Ketterer SG, Rappaport E. The use of indocyanine green for the evaluation of hepatic function and blood flow in man. Am J Dig Dis 1960;5:427-436.
7. Skak C, Keiding S. Methodological problems in the use of indocyanine green to estimate hepatic blood flow and ICG clearance in man. Liver 1987;7:155-162.
8. Molino G, Cavanna A, Avagnina P, Ballaré M, Torchio M. Hepatic clearance of D-sorbitol. Noninvasive test for evaluating functional liver plasma flow. Dig Dis Sci 1987;32:753-758.
9. Zeeh J, Lange H, Bosch J, Pohl S, Loesgen H, Eggers R, Navasa M, et al. Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroenterology 1988;95:749-759.
10. Molino G, Avagnina P, Ballaré M, Torchio M, Niro AG, Aurucci PE, Grosso M, et al. Combined evaluation of total and functional liver plasma flows and intrahepatic shunting. Dig Dis Sci 1991;36:1189-1196.
11. Adcock LH, Gray CH. The metabolism of sorbitol in the human subject. Biochem J 1957;65:554-560.
12. Keiding S, Engsted E, Ott P. Sorbitol as a test substance for measurement of liver plasma flow in humans (abstract). J Hepatol 1997;26:235.
13. Ott P, Keiding S, Bass L. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectropholometry and high-pressure liquid chromatography for concentration analysis. HEPATOLOGY 1993;18:1504-1515.
14. Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest Suppl 1966;18:S92:118-125.
15. Keiding S, Johansen S, Midtboll I, Rabol A, Christiansen L. Ethanol elimination kinetics in human liver and pig liver in vivo. Am J Physiol 1979;237:E316-E324.
16. Bass L, Keiding S, Winkler K, Tygstrup N. Enzymatic elimination of substrates flowing through the intact liver. J Theor Biol 1976;61:393-409.
17. Ott P, Keiding S, Bass L. Hepatic removal of two fractions of indocyanine green after bolus injection in the pig. Am J Physiol 1994;266:G1108-G1122.
18. Ranek L, Lindskov J, Tygstrup N, Winkler K. Splanchnic galactose uptake in patients with cirrhosis following single injection. Clin Physiol 1983;3:173-178.
19. Tygstrup N, Ranek L. Assessment of prognosis in fulminant hepatic failure. Semin Liver Dis 1986;6:129-137.
20. Rolando N, Gimson A, Wade J, Howard JP, Casewell M, Williams R. HEPATOLOGY 1993;17:196-201.